Sweltering heat problematic for people with dementia
By
Kristen Fischer
Jul 13, 2023
Scorching temperatures — think triple digits — are tough for all of us, but heat can be really dangerous for a person with dementia or Alzheimer’s disease. That’s why knowing what to do — and...
FDA grants full approval of Alzheimer’s drug Leqembi
By
Liza Berger
Jul 07, 2023
The Food and Drug Administration (FDA) late Thursday granted full approval of the early Alzheimer’s drug Leqembi (lecanemab), opening up long-awaited broad Medicare coverage of the medication shown to...
Deep sleep may buffer against memory loss in those with Alzheimer’s brain changes: study
By
Alicia Lasek
May 05, 2023
Deep sleep may help build cognitive reserve, increasing resilience against the effects of beta-amyloid brain changes, investigators report.
Scientists eye cell death as cause of Alzheimer’s, vascular dementia
By
Kristen Fischer
Sep 08, 2023
In a new study, researchers explain how cell death can lead to Alzheimer’s disease and vascular dementia — a discovery they say could pave the way for new treatments.
Study seeks to shed light on COVID-19’s impact on the brain
By
John Roszkowski
Sep 23, 2022
A global consortium of researchers is seeking to uncover the short-term and long-term impacts of COVID-19 on the brain to assess whether it can lead to cognitive impairments later in life such as Alzheimer’s...
No more lonely nights?
By
Gary Tetz
Aug 10, 2023
No one knows better than long-term care folks the unfortunate toll cognitive decline can take. So if you’re like me, and I wouldn’t wish that on anyone, you’re always interested in ways to keep your...
Patient advocates decry CMS decision on Alzheimer’s drug coverage
By
Alicia Lasek
Feb 24, 2023
The Alzheimer’s Association and others have strongly criticized a decision by CMS to stand by its highly restrictive coverage for new dementia drugs.
Doctor sounds alarm on quality, efficacy of Alzheimer’s supplement
By
Kristen Fischer
Feb 27, 2024
When it was sold as a prescription generic drug, galantamine was labeled accurately and it wasn’t contaminated. But that wasn’t the case when galantamine was sold as an over-the-counter dietary supplement,...
Not all older adults can get monoclonal antibodies for Alzheimer’s disease, study finds
By
Kristen Fischer
Sep 22, 2023
Even though newer monoclonal antibodies are available for Alzheimer’s disease, there are limits on the number of older adults who can receive them, a recent study published in Neurology finds.
BREAKING: FDA approves new experimental drug to treat early Alzheimer’s
By
Alicia Lasek
Jan 06, 2023
The Food and Drug Administration has approved the experimental Alzheimer’s drug Leqembi (lecanemab-irmb) for clinical use in patients with early disease.